Composite Scheme of Arrangement

Related Party Transactions for the half year ended September 30, 2023

Stock Exchange Letter Disclosure of Q2FY24 Earnings Call Audio Recording

Intimation of Board Meeting

Intimation of Schedule of Analyst/Institutional Investor Meeting

ESG Overview FY2022-23

Webcast Recording of 31st Annual General Meeting of the Company

Intimation of Schedule of Analyst/ Institutional Investor Meeting

Intimation of Schedule of Analyst/Institutional Investor Meeting

Intimation of Schedule of Analyst/Institutional Investor Meeting

Related Party Transactions for the half year ended March 31, 2023

Stock Exchange Letter Disclosure of Q1FY24 Earnings Call Audio Recording

Tax on Dividend for Final Dividend

Dividend Waiver Form

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Update relating to earnings call

Non-binding indication of interest to acquire shares of Taro Pharmaceutical Industries Ltd., Israel

Appointment of Director

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Disclosure of Q4FY23 Earnings Call Audio Recording

Update on US FDA Inspection at Mohali Facility

Update on IT Security Incident

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Intimation of IT Security Incident

Interim Dividend Waiver Form for the financial year 2022-23

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Disclosure of Earnings Call Audio Recording

Outcome of postal ballot and disclosure of voting results- Appointment of Mr. Sanjay Asher as an Independent Director

Sustainability Report 2021-22

Notice of Postal Ballot for Appointment of Mr. Sanjay Asher & Postal Ballot Form

Related Party Transactions for half year ended 30.09.2022

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Disclosure of Earnings Call Audio Recording

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Webcast Recording of 30th AGM

Voting Results and Scrutinizer’s Report of 30th AGM

ESG Overview 2021-22

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Publication for 30th AGM and Evoting

Publication of 30th Annual General Meeting to be held by VC

Form for waiver-forgoing right to receive Final Dividend for financial year 2021-22

Intimation under Regulation 30 – Retirement of Chairman

Publication of unaudited financial results for Q1

Intimation of the 30th Annual General Meeting

Stock Exchange Letter Disclosure of Earnings Call Audio Recording

Self-declaration for Non-resident Shareholder

Outcome of Board Meeting – July 2022

Intimation of Board Meeting July 2022

Closure of Trading Window Q1 (2022-23)

Consolidated Related Party Transactions for half year ended 31.03.2022

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Intimation under Regulation 30 – 31 May 2022

Stock Exchange Letter Disclosure of Earnings Call Audio Recording

Outcome of Board Meeting – May 2022

Intimation under Regulation 30 – 30 May 2022 (Approval of Scheme of Amalgamation)

Intimation under Regulation 30 – 30 May 2022 (Appointment of Lead Independent Director/ Re-appointment of Directors)

Annual Secretarial Compliance Report

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Intimation of Board Meeting May 2022

Intimation under Regulation 30 – 10th May, 2022

Intimation under Regulation 30- 29th March, 2022

Intimation under Regulation 30 – March 21, 2022

Intimation under Regulation 30- 8th March, 2022

Intimation under Regulation 30 – February 22, 2022

Intimation under Regulation 30- 1st February, 2022

Disclosure under Regulation 30 of SEBI Listing Regulations – Signing of Binding Memorandum of Understanding as to Material Terms of Settlement with the Direct Purchaser and End-Payor Plaintiffs in the In re Ranbaxy Generic Drug Application Antitrust Litigation in the U.S. District Court for the District of Massachusetts (USA)

Closure of Trading Window

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Interim Dividend Waiver Form_2021-22

Outcome of Board Meeting held on Jan 31, 2022

SPIL Intimation of Board Meeting January 2022

Consolidated Related Party Transactions for half year ended 30.09.2021

Intimation under Regulation 30- 30th November, 2021

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Signing of settlement agreements with the Direct Purchaser Plaintiffs in the In re Generic Pharmaceuticals Pricing Antitrust Litigation in the Eastern District of Pennsylvania (USA) by our 2 subsidiary companies.

Outcome of Board Meeting held on Nov 02, 2021

Closure of trading window

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Webcast Recording of 29th Annual General Meeting of the Company

Intimation to exchange Sanction of Scheme of Amalgamation and Merger of Sun Pharma Global FZE with SPIL

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Resignation of Mr. Vivek Channd Sehgal

Intimation under Regulation 30- 1st September, 2021

Voting Results of 29th AGM and Scrutiniser’s Report

Proceedings of 29th AGM and Intimation of Changes in Directors

Chairman Speech at the 29th Annual General Meeting held on 31 August 2021

Newspaper Advertisement for Notice of 28th Annual General Meeting and E-voting – Post-dispatch

Form for waiver-forgoing right to receive Final Dividend for financial year 2020-21

Newspaper Advertisement for Notice of 28th Annual General Meeting, E-voting and Book Closure – Pre-dispatch

SPIL Intimation of AGM and Book Closure

Outcome of Board Meeting held on July 30, 2021

Newspaper Advertisement for Notice for transfer of equity shares and unclaimed Dividend to IEPF

SPIL Intimation of Board Meeting July 2021

Annual Secretarial Compliance Report

Consolidated Related Party Transactions for half year ended 31.03.2021

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Intimation of Acquisition of trademarks and patent license for Dapagliflozin and its combinations from AstraZeneca AB

Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting

Outcome of the Board Meeting – May 2021

Intimation for Appointment of Additional Independent Directors on the Board of the Company

SPIL Intimation of Board Meeting May 2021

Intimation under Regulation 30 of Listing Regulations

Clarification to Stock Exchanges on News Item

Intimation under Regulation 30 of Listing Regulations

Webcast Recording for Tribunal Called Meeting of Equity Shareholders of the Company held on March 16, 2021

Intimation under Regulation 30 of Listing Regulations

Intimation under Regulation 30 of Listing Regulations

Voting Results of the NCLT Convened Meeting of Equity Shareholders held on March 16, 2021 and Scrutinizer’s Reports

Proceedings of the NCLT Convened Meetings of Unsecured Creditors and Equity Shareholders held on March 16, 2021

Update on Intimation under Regulation 30 of Listing Regulations

Intimation under Regulation 30 of Listing Regulations

Newspaper Advertisement for NCLT Meetings of Equity Shareholders and Unsecured Creditors

Intimation Letter for Conclusion of settlement proceedings with SEBI

Notice of NCLT Convened Meeting of Unsecured Creditors

Notice of NCLT Convened Meeting of Equity Shareholders

Newspaper Advertisement for Intimation of Record Date for Payment of Interim Dividend

FORM NO 15G

Interim Dividend Waiver Form_2020-21

FORM NO 15H

Outcome of the Board Meeting – January 2021

FORM NO 10F

Intimation to Stock Exchange for considering Declaration of Interim Dividend

SPIL Intimation of Board Meeting January 2021

StockExchangeIntimationSUNAZ28052021

Webcast Recording of 28th Annual General Meeting of the Company for the year 2019-20

Outcome of Board Meeting – November 2020

SPIL Intimation of Board Meeting November 2020

Scheme of Amalgamation and Merger

Board Resolution approving Scheme of Amalgamation and Merger

Related Party Disclosure on consolidated basis for the half year ended September 30, 2020

Post Buy-Back Public Announcement – September 26, 2020

Intimation of Closure of Buy Back – September 25, 2020

Secretarial Audit Report of Material Subsidiaries_2019-20

Voting Results for the 28th Annual General Meeting and Scrutinizer’s Consolidated Report

Outcome of 28th Annual General Meeting

Chairman Speech at the 28th Annual General Meeting held on 27 August 2020

Newspaper Advertisement for Notice of 28th Annual General Meeting, E-voting and Book Closure

BUSINESS RESPONSIBILITY REPORT -FY2019-20

Self Declaration Format for Non-Resident Shareholders

Notice of the 28th Annual General Meeting

SPIL ANNUAL REPORT -FY2019-20

EMPLOYEES’ STOCK OPTION SCHEME-Disclosure under SEBI (Share Based Employee Benefits)Regulations2014 as on Mar 312020

Update on Intimation under Regulation 30 of Listing Regulations

Form for waiver-forgoing right to receive Final Dividend for financial year 2019-2020_Final

Intimation under Regulation 30 of Listing Regulations

Outcome of the Board Meeting – July 2020

Newspaper Advertisement for Notice for transfer of equity shares and unclaimed Dividend to IEPF

SPIL Intimation of Board Meeting July 2020

Related Party Disclosure on consolidated basis for the half year ended March 31, 2020

Outcome of Board Meeting – May 2020

SPIL Intimation of Board Meeting May 2020

Stock Exchange Letter Update on Halol facility

Additional details for OAI classification for Halol facility

Corrigendum to Public Announcement for Buy-Back of Equity Shares – March 24, 2020

Public Announcement for Buy-Back of Equity Shares – March 18, 2020

Outcome of the Board Meeting March 2020 – Approval of Buy-Back

SPIL Intimation of Board Meeting March 2020

Newspaper Advertisement for Intimation of Record Date for payment of Interim Dividend

Outcome of the Board Meeting – February 2020

Interim Dividend Waiver Form

Intimation to Stock Exchange for considering Declaration of Interim Dividend

SPIL Intimation of Board Meeting February 2020

Intimation to Stock Exchange for NCLT Order on Composite Scheme of Arrangement

Update on US FDA Halol Inspection

Stock Exchange Letter Antitrust Litigation in US

Outcome of Board Meeting – November 2019

SPIL Intimation of Board Meeting November 2019

Related Party Disclosure on consodilated basis for half year ended September 30, 2019

Chairman Speech at the 27th Annual General Meeting held on August 28, 2019

Outcome of Board Meeting – August 2019

Clarification/Confirmation on News Item

Newspaper Advertisement for Notice of 27th Annual General Meeting, E-voting and Book Closure

SPIL Intimation of Board Meeting August 2019

SPIL Intimation of AGM date and Book Closure

EMPLOYEES’ STOCK OPTION SCHEMES – Disclosure under SEBI (Share Based Employee Benefits) Regulations, 2014 as on March 31, 2019

Business Responsibility Report FY2018-19

Dividend Waiver Form 2018-19

Voting Results alongwith Scrutinizer’s Report of TCM held on June 04, 2019

Proceedings of the NCLT Convened Meeting of Shareholders and Unsecured Creditors

Stock Exchange clarification on news item

Scrutinizer Report SPIL NCLT Meeting 04 06 2019 Unsecured Creditors

Advertisement for Notice for transfer of equity shares and unclaimed dividend to IEPF

Notice of Tribunal Convened Meeting Unsecured Creditors June 04, 2019

Outcome of the Board Meeting – May 28, 2019

SPIL Intimation of BM May 2019

Stock Exchange Intimationm Of Advertisement

Sun Pharma – Attendance Slip for NCLT Convened Meeting for Equity Shareholders

Sun Pharma – Notice of NCLT Convened Meeting including Proxy Form and Attendance Slip for Equity Shareholders

Sun Pharma – Proxy Form for NCLT Convened Meeting for Equity Shareholders

Related Party Disclosure on consolidated basis for half year ended 31st March, 2019

Notice of Board Meeting – February 12, 2019

Outcome of the Board Meeting – February 12, 2019

Observation Letter – BSE

Observation Letter – NSE

Stock Exchange Letter Sun Pharma Investor Update

Stock Exchange Letter to SEBI on alleged second whistleblower complaint filed against Sun

Stock Exchange Letter update on commercialsed XELPROS in US

Stock Exchange Letter Completion of transaction Pola Pharma, Japan

Stock Exchange Letter Clarification on Recent Media Reports

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Letter Intimation of settlement in re Modafinil Antitrust Litigation in US with certain plaintiffs

Notice of Board meeting – Nov 13, 2018

Outcome of Board meeting – Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Shareholding Pattern – September 30, 2018

Investor – Shareholder Information – Statutory Communications – 2018

Voting Results of 26th Annual General Meeting to Stock Exchanges along with Scrutinizers Report

Composite Scheme of Arrangement

Chairman speech at 26th Annual General Meeting held on September 26, 2018

Proceedings of 26th Annual General Meeting

Clarification to Stock Exchanges on Mohali facility

Clarification to Stock Exchanges on news regarding Halol facility

Newspaper Advertisement – Notice of 26th AGM, E-voting and Book Closure – English and Gujarati

Business Responsibility Report FY2017-18

Form for waiver-forgoing right to receive Dividend for financial year ended March 31, 2018

EMPLOYEES’ STOCK OPTION SCHEMES – Disclosure under SEBI (Share Based Employee Benefits) Regulations, 2014 as on March 31, 2018

Notice of 26th Annual General Meeting

Intimation of Book closure and AGM date

Outcome of Board Meeting – August 14, 2018

Notice of Board Meeting – August 14, 2018

Clarification on news regarding Halol

Voting Results of NCLT Meeting of Equity Shareholders

Proceedings of National Company Law Tribunal Meetings held on June 01, 2018

Outcome of Board Meeting May 25, 2018

Notice of Board Meeting – May 25, 2018

Allotment of Equity Shares under SUN ESOS 2015 – May 24, 2018

Newspaper Advertisement regarding Notice for NCLT Convened Meeting of Equity Shareholders & Unsecured Creditors and Notice for Remote E-Voting for NCLT Convened Meeting of Equity Shareholders

Shareholding Pattern

SPIL – Attendance Slip for NCLT Convened Meeting of Unsecured Creditors

SPIL – NCLT Convened Meeting Notices of Unsecured Creditors along with Proxy Form and Attendance Slip

SPIL – Attendance Slip for NCLT Convened Meeting of Equity Shareholders

SPIL – NCLT Convened Meeting Notices of Equity shareholders along with Proxy Form

Intimation to stock exchanges Mar 10 2018

Update on USFDA Halol Inspection

Disclosure to Stock Exchanges under Regulation 30 – Updates

Outcome of Board Meeting – February 14, 2018

Allotment of Equity Shares under SUN ESOS 2015 – February 14, 2018

SPIL Reply to BSE on News Clarification Ankleshwar unit Feb 5 2018

SPIL Reply to NSE on News Clarification Ankleshwar unit Feb 5, 2018

Notice of Board Meeting – February 14, 2018

Disclosure to Stock Exchanges under Regulation 30 – Updates

Scheme of Arrangement – Compliance of Regulation 37 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015

Disclosure to Stock Exchanges under Regulation 30

Outcome of Board Meeting 14 November 2017

Outcome of Allotment Committee Meeting 14 November 2017

Notice of Board Meeting – November 14 2017

Outcome of Allottment Commitee Meeting September 26 2017

Update on US FDA Dadra Inspection

Voting Results for the 25th AGM and Scrutinizers Report

Chairman and Managing Director Speech at 25th Annual General Meeting held on September 26, 2017

Proceedings of 25th Annual General Meeting

Newspaper Advertisement Notice of AGM Evoting and Book Closure English Ahmedabad Edition

Newspaper Advertisement Notice of AGM Evoting and Book Closure English Mumbai Edition

Newspaper Advertisement Notice of AGM Evoting and Book Closure Gujarati Ahmedabad Edition

Form for waiver-forgoing of right to receive Dividend for the financial year ended March 31 2017

Business Responsibility Report 2016-17

ESOS – Disclosure under SEBI (Share Based Employee Benefits) Regulations, 2014 as on March 31, 2017

SPIL Notice of 25th AGM 2016-17

SPIL Attendance Slip and Proxy Form 2016-17

Outcome of Allottment Commitee Meeting August 11, 2017

Outcome of Board Meeting August 11, 2017

Notice of Board Meeting August 11 2017

Intimation of change in key managerial person for determining materiality of an event or information

Proceedings of NCLT Convened Meetings held on June 20, 2017

Scrutinizer’s Report for the NCLT Convened Meeting of Unsecured Creditors

Consolidated Scrutinizer’s Report for the NCLT Convened Meeting of Equity Shareholders

Voting Results of NCLT Convened Meeting of Equity Shareholders

Correction Letter to the Letter to Stock Exchange for outcome of Board Meeting May 26 2017

Outcome of Board Meeting May 26, 2017

Outcome of Allottment Commitee Meeting May 26, 2017

Newspaper Advertisement regarding Notice for Postal Ballot and Remote E-voting for the National Company Law Tribunal Convened Meeting of Equity Shareholders

Newspaper Advertisement regarding Notice of the National Company Law Tribunal Convened Meetings of Equity Shareholders and Unsecured Creditors

Notice of Board Meeting May 26, 2017

Notice of NCLT Convened Meeting of Equity Shareholders including Proxy Form and Attendance Slip

Notice of Tribunal Convened Meeting of Unsecured Creditors of the Company

Postal Ballot Form for NCLT Convened Meeting of Equity Shareholders

Acquisition of Thallion Pharmaceuticals Inc.

Observation letter – BSE

Observation letter – NSE

Outcome of Board Meeting February 14, 2017

Allottment Commitee Meeting Outcome of Meeting February 14, 2017

Notice of Board Meeting – February 14, 2017

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement for Amalgamation

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement for Amalgamation

SPIL Reply to BSE on news clarification Ahmednagar unit Dec 29, 2016

SPIL Reply to NSE on news clarification Ahmednagar unit Dec 29, 2016

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Scheme of Arrangement – Compliance of Regulation 37 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

Update on acquisition of Ocular Technologies, Sarl – closure of transaction

Stock Exchange Letter – Reply

Stock Exchange Letter – Update on USFDA Inspection for Halol facility

Sun Pharma to acquire Biosintez in Russia

Allottment Commitee Meeting Outcome of Meeting

Stock Exchange Intimation on CFO

Notice of Board Meeting – 10th November, 2016

Change in Window Closure Date for trading by Designated Persons

Completion of Buyback and Submission of Post Buyback Public Announcement

Submission of Corrigendum to the Post Buyback Public Announcement

Receipt of approval for reclassification of shares under Regulation 31A(7) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015

Submission of new set of Articles of Association of the Company

September 22, 2016

Voting Results of 24th Annual General Meeting held on September 17, 2016

September 19, 2016

Proceedings of 24th Annual General Meeting held on September 17, 2016

September 19, 2016

Srcutinizer’s Report on Voting Results of 24th Annual General Meeting held on September 17, 2016

September 19, 2016

Chairman and Managing Director Speech at 24th Annual General Meeting held on September 17, 2016

September 19, 2016

Letter of offer for Buyback

September 14, 2016

Draft Articles of Association of SPIL

August 27, 2016

Form for waiver forgoing right to receive Dividend for year ended 31-03-16

August 18, 2016

NOTICE OF 24th ANNUAL GENERAL MEETING

August 17, 2016

Business Responsibility Report 2015-16

August 17, 2016

Notice of Board meeting scheduled on August 12, 2016

August 05, 2016

Draft letter of offer for Buyback – Sun Pharmaceutical Industries Limited

July 08, 2016

Public Announcement of Sun Pharmaceutical Industries Limited for buyback through Tender Offer

June 28, 2016

Outcome of Board Meeting dated June 23, 2016

June 23, 2016

Outcome of the Board meeting held on 30th May, 2016

May 30, 2016

Intimation pertaining to Request letter(s) received from certain Promoter group under Regulation 31A of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

May 23, 2016

Notice of Board meeting scheduled on 30th May, 2016

May 13, 2016

Intimation of withdrawal of CARE rating at Company’s request

April 07, 2016

Termination of collaboration established in 2011 between affiliates of Merck Sharp & Dohme and Sun Pharmaceutical Industries Limited

February 15, 2016

Outcome of the Board meeting held on 12th February, 2016

February 12, 2016

Notice of Board Meeting scheduled on 12th February 2016

January 29, 2016

CCI approval for sale of CNS division to Strides

January 22, 2016

Disclosure to Stock Exchanges under Regulation 30

Authorized KMPs for determining materiality of an event or information

November 30, 2015

Update on Wind Energy Project

November 24, 2015

Result of Postal Ballot as per Clause 35A of the Listing Agreement alongwith Scrutinizers Report

November 06, 2015

Report on Proceedings of 23rd AGM with Scrutinizer report & voting results

November 02, 2015

23rd AGM Chairman Speech

October 31, 2015

Form for waiver forgoing right to receive Dividend for year ended 31-03-15

October 20, 2015

Notice of 23rd Annual General Meeting

October 06, 2015

Business Responsibility Report 2014-15

October 06, 2015

Notice of Postal Ballot & Postal Ballot form

October 05, 2015

Voting Result of Court Convened Meeting of SPIL to consider the Scheme of Merger of SPGI with the Company

June 06, 2015

Notice for the Court convened meeting for approval of the Scheme of Merger of Sun Pharma Global Inc with Sun Pharmaceutical Industries Ltd.

May 18, 2015

Draft Scheme of Amalgamation and other documents pertaining to the proposed merger of Sun Pharma Global Inc. with the Company

March 12, 2015

Clarification regarding CCI approval to the Scheme of Arrangement between Ranbaxy and Sun Pharma

December 01, 2014

Outcome of 22nd AGM 2014, Voting Results as per 35A and Scrutinizer Reports

October 01, 2014

22nd AGM Chairman Speech

September 29, 2014

Notice of 22nd Annual General Meeting

September 04, 2014

Form IV contained in Schedule II to the Combination Regulations under Sec 29(2) of Competition Act, 2002 (as amended)

September 04, 2014

Business Responsibility Report 2013-14

September 02, 2014

Intimation pertaining to communication from the Competition Commission of India (CCI)

August 27, 2014

Outcome of Court Convened Meeting & Poll Results

August 26, 2014

Form for waiver forgoing right to receive Dividend for year ended 31-03-14

August 26, 2014

Notice of Court Convened Meeting on 22.08.2014, Scheme, ExplStmt, Attd Slip & Proxy Form

July 29, 2014

Scheme of Arrangement between Ranbaxy Laboratories Limited And Sun Pharmaceutical Industries Limited

May 12, 2014

Proceedings & Results of Court convened Meeting of Equity Shareholders held on May 05, 2014

May 09, 2014

Scheme of arrangement & reconstruction between Sun Pharma Global FZE & Sun Pharmaceutical Industries Ltd.

January 21, 2014

21st AGM Chairman Speech

October 01, 2013

Business Responsibility Report 2012-13

September 05, 2013

Notice of Adjourned Twentieth Annual General Meeting

September 05, 2013

SPIL Proxy Form & Attendance Slip for Adjourned Twentieth AGM & Twenty-first AGM

September 05, 2013

Notice of Twenty-first Annual General Meeting

September 05, 2013

Form for waiver forgoing right to receive Dividend year ended 31-03-2013

September 04, 2013

Disclosure UR 13 (6) of the SEBI Prohibition of Insider Trading

August 05, 2013

Stock Exchange Intimation of Record Date for Bonus Shares

July 18, 2013

Result of Postal Ballot

July 15, 2013

Quarterly compliance report of the Corporate Governance 30-06-2013

July 03, 2013

Postal Ballot Form 30.05.2013

June 10, 2013

Request for Bonus Equity Share in Electronic Form & Envelopes

June 10, 2013

Postal Ballot Notice 30.05.2013

June 10, 2013

Stock Exchange Intimation of Postal Ballot 30.05.2013

June 10, 2013

Quarterly compliance report of the Corp. Gov.31-03-2013

April 01, 2013

Notice of Board Meeting for quarter end 31-12-2012

January 23, 2013

Notice of Convening the meeting of Equity Shareholders

January 08, 2013

Quarterly compliance report of the Corp. Gov.31-12-2012

January 07, 2013

Code of Conduct for Directors and Senior Management

December 14, 2012

Notice of Board Meeting for quarter end 30-09-2012

October 22, 2012

Disclosure UR 13 (6) of the SEBI Prohibition of Insider Trading

October 12, 2012

Notice of Twentieth Annual General Meeting

October 11, 2012

Notice for 20th Annual General Meeting

October 11, 2012

SPIL Proxy Form & Attendance Slip

October 11, 2012

Disclosure UR 13 (6) of the SEBI Prohibition of Insider Trading

October 10, 2012

Quarterly compliance report of the Corp. Gov.30-09-2012

October 09, 2012

Disclosure UR 13 (6) of the SEBI Prohibition of Insider Trading

October 04, 2012

Rising Funds & Fixation of Book Closure Date

October 03, 2012

Disclosure UR 13 (6) of the SEBI Prohibition of Insider Trading

September 27, 2012

Form of Waiverforgoing the Right to receive the dividend 31-03-2012

August 13, 2012

Intimation Restructuring, Interim Dividend & Record Date 3-8-12

August 06, 2012

Quarterly compliance report of the Corp. Gov.30-06-2012

July 03, 2012

Intimation of Compliance as per Clause 47 (c) as on 31.03.2012

April 24, 2012

Quarterly compliance report of the Corp. Gov.31-03-2012.pdf

April 03, 2012

Notice of Board Meeting for quarter end 31-12-2011

January 30, 2012

Quarterly compliance report of the Corp. Gov.31-12-2010

January 11, 2012

Notice to acquire all the outstanding shares in Taro Pharma

October 18, 2011

Notice of Board Meeting for quarter end 30-09-2011

October 18, 2011

Security pledge revocation letter (Revoked & Pledged)

October 13, 2011

Acquisition of Shares & Takeovers code intimation

September 27, 2011

Security pledge revocation letter (Pledged )

September 19, 2011

Form of Waiverforgoing the Right to receive the dividend 31-03-2011

September 05, 2011

SPIL Proxy Form & Attendance Slip

August 19, 2011

Security pledge revocation letter (Revoked)

July 15, 2011

Security pledge revocation letter (Revoked & Pledged)

July 05, 2011

Security pledge revocation letter (Revoked & Pledged)

May 11, 2011

Security pledge revocation letter (Pledged )

May 11, 2011

Notice of Nineteenth Annual General Meeting

April 19, 2011

Security pledge revocation letter (Revoked)

March 30, 2011

Security pledge revocation letter (Revoked)

February 18, 2011

Security pledge revocation letter (Pledged )

January 28, 2011

Result of the Postal Ballot

November 12, 2010

Security pledge revocation letter (Pledged )

November 11, 2010

Security pledge revocation letter (Revoked & Pledged)

September 30, 2010

18th AGM Chairman Speech

September 26, 2010

Notice of Proceedings Eighteenth AGM

September 24, 2010

Notice Split of Shares fro Rs.5 to Re.1 per share

September 24, 2010

Security pledge revocation letter (Revoked & Pledged)

September 07, 2010

Security pledge revocation letter (Revoked)

September 01, 2010

Form of Waiverforgoing the Right to receive the dividend 31-03-2010

August 19, 2010

Fixation of Book Closure Date for payment of Dividend

August 10, 2010

Notice of Eighteenth Annual General Meeting

June 14, 2010

Security pledge revocation letter (Revoked & Pledged)

May 22, 2010

Notice of Board Meeting for quarter end 31-03-2010

May 07, 2010

Appointed Shri. Kal Sundaram, as an additional Director on the Board

April 02, 2010

Security pledge revocation letter (Revoked)

March 26, 2010

Quarterly compliance report of the Corp. Gov. 31-12-2009

January 04, 2010

Security pledge revocation letter (Revoked)

December 18, 2009

Security pledge revocation letter (Pledged )

November 03, 2009

Security pledge revocation letter (Revoked & Pledged)

October 20, 2009

Notice of Board Meeting for quarter end 30-09-2009

October 10, 2009

Notice for expiry of HSR waiting period in U.S. for Taro Tender Offer

September 14, 2009

Acquisition of Shares & Takeovers code intimation

September 12, 2009

Notice of Proceedings Seventeenth AGM

September 12, 2009

17th AGM Chairman Speech

September 11, 2009

Security pledge revocation letter (Revoked & Pledged)

August 10, 2009

Notice of Seventeenth Annual General Meeting

July 11, 2009

Quarterly compliance report of the Corp. Gov. 30-06-2009

July 02, 2009

Outcome of Board meeting 31-03-2009

May 30, 2009

Details of share holding, in terms of Regulation 8(3)

April 20, 2009

Quarterly compliance report of the Corp. Gov. 31-03-2009

April 07, 2009

Form of Waiverforgoing the Right to receive the dividend 31-03-2009

March 31, 2009

Security pledge revocation letter (Revoked)

March 13, 2009

Security pledge revocation letter (Pledged )

February 10, 2009

Notice of Board Meeting for quarter end 31-12-2008

January 16, 2009

Quarterly compliance report of the Corp. Gov. 30-09-2008

October 03, 2008

16th AGM Chairman Speech

September 06, 2008

Notice of Sixteenth Annual General Meeting

August 27, 2008

Form of Waiverforgoing the Right to receive the dividend 31-03-2008

August 08, 2008

Quarterly compliance report of the Corp. Gov. 31-03-2008

April 12, 2008

Allotment of Equity Shares against conversion of further FCCBs

March 20, 2008